Country: United States
Language: English
Source: NLM (National Library of Medicine)
FLURALANER (UNII: WSH8393RM5) (FLURALANER - UNII:WSH8393RM5)
Merck Sharp & Dohme Corp.
TOPICAL
PRESCRIPTION
Bravecto kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis ) and the treatment and control of Ixodes scapularis (black-legged tick) and Haemaphysalis longicornis (Asian longhorned tick) infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. Bravecto is also indicated for the treatment and control of Dermacentor variabilis (American dog tick) infestations for 8 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. There are no known contraindications for the use of the product.
Bravecto is available in three strengths for use in cats (112.5, 250, and 500 mg fluralaner per tube). Each tube is packaged individually in a pouch. Product may be supplied in 1 or 2 tubes per carton.
New Animal Drug Application
BRAVECTO- FLURALANER SOLUTION MERCK SHARP & DOHME CORP. ---------- BRAVECTO (FLURALANER TOPICAL SOLUTION) FOR CATS CAUTION: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: Each tube is formulated to provide a minimum dose of 18.2 mg/lb (40 mg/kg) body weight. Each milliliter contains 280 mg of fluralaner. The chemical name of fluralaner is (±)-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5- dihydroisoxazol-3-yl]-2-methyl-_N_-[2-oxo-2-(2,2,2 - trifluoroethylamino)ethyl]benzamide. Inactive ingredients: dimethylacetamide, glycofurol, diethyltoluamide, acetone INDICATIONS: Bravecto kills adult fleas and is indicated for the treatment and prevention of flea infestations (_Ctenocephalides felis_) and the treatment and control of _Ixodes scapularis_ (black-legged tick) and _Haemaphysalis longicornis_ (Asian longhorned tick) infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. Bravecto is also indicated for the treatment and control of _Dermacentor variabilis_ (American dog tick) infestations for 8 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater. DOSAGE AND ADMINISTRATION: Bravecto should be administered topically as a single dose every 12 weeks according to the DOSAGE SCHEDULE below to provide a minimum dose of 18.2 mg/lb (40 mg/kg) body weight. Bravecto may be administered every 8 weeks in case of potential exposure to _Dermacentor variabilis_ ticks (see EFFECTIVENESS). DOSAGE SCHEDULE: BODY WEIGHT RANGES (LB) FLURALANER CONTENT (MG/TUBE) TUBES ADMINISTERED 2.6 – 6.2 112.5 One >6.2 – 13.8 250 One ® * * >13.8 – 27.5 500 One A veterinarian or veterinary technician should demonstrate or instruct the pet owner regarding the appropriate technique for applying Bravecto topically to cats prior to first use. STEP 1: Immediately before use, open the pouch and remove the tube. Put on gloves. Hold the tube at the crimped end with the cap in an upright position (tip up) Read the complete document